Cargando…
Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?
Neurodegenerative diseases are characterized by the progressive loss of structure and/or function of both neurons and glial cells, leading to different degrees of pathology and loss of cognition. The hypothesis of circuit reconstruction in the damaged brain via direct cell replacement has been pursu...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391848/ https://www.ncbi.nlm.nih.gov/pubmed/34440761 http://dx.doi.org/10.3390/cells10081992 |
_version_ | 1783743368309768192 |
---|---|
author | Bonaventura, Gabriele Munafò, Antonio Bellanca, Carlo Maria La Cognata, Valentina Iemmolo, Rosario Attaguile, Giuseppe Antonino Di Mauro, Rosaria Di Benedetto, Giulia Cantarella, Giuseppina Barcellona, Maria Luisa Cavallaro, Sebastiano Bernardini, Renato |
author_facet | Bonaventura, Gabriele Munafò, Antonio Bellanca, Carlo Maria La Cognata, Valentina Iemmolo, Rosario Attaguile, Giuseppe Antonino Di Mauro, Rosaria Di Benedetto, Giulia Cantarella, Giuseppina Barcellona, Maria Luisa Cavallaro, Sebastiano Bernardini, Renato |
author_sort | Bonaventura, Gabriele |
collection | PubMed |
description | Neurodegenerative diseases are characterized by the progressive loss of structure and/or function of both neurons and glial cells, leading to different degrees of pathology and loss of cognition. The hypothesis of circuit reconstruction in the damaged brain via direct cell replacement has been pursued extensively so far. In this context, stem cells represent a useful option since they provide tissue restoration through the substitution of damaged neuronal cells with exogenous stem cells and create a neuro-protective environment through the release of bioactive molecules for healthy neurons, as well. These peculiar properties of stem cells are opening to potential therapeutic strategies for the treatment of severe neurodegenerative disorders, for which the absence of effective treatment options leads to an increasingly socio-economic burden. Currently, the introduction of new technologies in the field of stem cells and the implementation of alternative cell tissues sources are pointing to exciting frontiers in this area of research. Here, we provide an update of the current knowledge about source and administration routes of stem cells, and review light and shadows of cells replacement therapy for the treatment of the three main neurodegenerative disorders (Amyotrophic lateral sclerosis, Parkinson’s, and Alzheimer’s disease). |
format | Online Article Text |
id | pubmed-8391848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83918482021-08-28 Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? Bonaventura, Gabriele Munafò, Antonio Bellanca, Carlo Maria La Cognata, Valentina Iemmolo, Rosario Attaguile, Giuseppe Antonino Di Mauro, Rosaria Di Benedetto, Giulia Cantarella, Giuseppina Barcellona, Maria Luisa Cavallaro, Sebastiano Bernardini, Renato Cells Review Neurodegenerative diseases are characterized by the progressive loss of structure and/or function of both neurons and glial cells, leading to different degrees of pathology and loss of cognition. The hypothesis of circuit reconstruction in the damaged brain via direct cell replacement has been pursued extensively so far. In this context, stem cells represent a useful option since they provide tissue restoration through the substitution of damaged neuronal cells with exogenous stem cells and create a neuro-protective environment through the release of bioactive molecules for healthy neurons, as well. These peculiar properties of stem cells are opening to potential therapeutic strategies for the treatment of severe neurodegenerative disorders, for which the absence of effective treatment options leads to an increasingly socio-economic burden. Currently, the introduction of new technologies in the field of stem cells and the implementation of alternative cell tissues sources are pointing to exciting frontiers in this area of research. Here, we provide an update of the current knowledge about source and administration routes of stem cells, and review light and shadows of cells replacement therapy for the treatment of the three main neurodegenerative disorders (Amyotrophic lateral sclerosis, Parkinson’s, and Alzheimer’s disease). MDPI 2021-08-05 /pmc/articles/PMC8391848/ /pubmed/34440761 http://dx.doi.org/10.3390/cells10081992 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Bonaventura, Gabriele Munafò, Antonio Bellanca, Carlo Maria La Cognata, Valentina Iemmolo, Rosario Attaguile, Giuseppe Antonino Di Mauro, Rosaria Di Benedetto, Giulia Cantarella, Giuseppina Barcellona, Maria Luisa Cavallaro, Sebastiano Bernardini, Renato Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? |
title | Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? |
title_full | Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? |
title_fullStr | Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? |
title_full_unstemmed | Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? |
title_short | Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? |
title_sort | stem cells: innovative therapeutic options for neurodegenerative diseases? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391848/ https://www.ncbi.nlm.nih.gov/pubmed/34440761 http://dx.doi.org/10.3390/cells10081992 |
work_keys_str_mv | AT bonaventuragabriele stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases AT munafoantonio stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases AT bellancacarlomaria stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases AT lacognatavalentina stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases AT iemmolorosario stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases AT attaguilegiuseppeantonino stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases AT dimaurorosaria stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases AT dibenedettogiulia stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases AT cantarellagiuseppina stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases AT barcellonamarialuisa stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases AT cavallarosebastiano stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases AT bernardinirenato stemcellsinnovativetherapeuticoptionsforneurodegenerativediseases |